` LVTX (LAVA Therapeutics NV) vs S&P 500 Comparison - Alpha Spread

LVTX
vs
S&P 500

Over the past 12 months, LVTX has underperformed S&P 500, delivering a return of -9% compared to the S&P 500's +14% growth.

Stocks Performance
LVTX vs S&P 500

Loading
LVTX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LVTX vs S&P 500

Performance Gap Between LVTX and GSPC
HIDDEN
Show

Performance By Year
LVTX vs S&P 500

Loading
LVTX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
LAVA Therapeutics NV vs Peers

S&P 500
LVTX
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
HIDDEN
Show
Back to Top